Autism spectrum disorder (ASD) affects approximately 2% of children in the United States
(US) yet its etiology is unclear and effective treatments are lacking. Therapeutic interventions …

Autism spectrum disorder is defined by two core symptoms: a deficit in social communication
and the presence of repetitive behaviors and/or restricted interests. Currently, there is no US …

Autism spectrum disorder is an increasingly prevalent neurodevelopmental disorder in the
world today, with an estimated 2% of the population being affected in the USA. A major …

Propranolol, a non-cardioselective β1, 2 blocker, is most commonly recognised for its
application in the therapy of various cardiovascular conditions, such as hypertension …

Objectives: To date, there is no single medication prescribed to alleviate all the core
symptoms of Autism Spectrum Disorder (ASD; National Institute of Health and Care …

Autism, also known as an autism spectrum disorder, is a complex neurodevelopmental
disorder usually diagnosed in the first three years of a child's life. A range of symptoms …

Rationale Autism spectrum disorder (ASD) is characterized by impaired social
communication and is also frequently characterized by co-occurring anxiety. Propranolol is …

The prevalence of autism spectrum disorder (ASD) continues to see a trend upward with a
noticeable increase to 1 in 36 children less than 8 years of age in the recent MMWR. There …

Beversdorf et al../fpsyt.. therefore propose the explicit inclusion of “Phase 2m” as part of the
pathway of clinical drug development, specifically for the development of a biomarker profile …

Autistic spectrum disorder (ASD) is a complicated developmental disease characterized by
persistent difficulties in social interaction, speech and nonverbal communication, and …